Published in Clinical Trials Week, June 27th, 2005
This would begin Phase I clinical trials in human volunteers with NEUMUNE(TM) (HE2100) in the United States. A similar Phase I clinical trial for NEUMUNE is currently ongoing in the Netherlands.
NEUMUNE is being developed for the treatment of Acute Radiation Syndrome (ARS). ARS is a potentially lethal condition caused by high-dose radiation exposure that might result from a nuclear or radiological terrorist attack or from an accident at a nuclear facility.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.